Evidence map›Paper›PMID 41406507›Full record

ArticleEBioMedicine2026

Corrigendum to "Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies", EBioMedicine. 2025 Nov;121:105967. doi: 10.1016/j.ebiom.2025.105967.

Edoardo G Ostinelli, Georgia Salanti, Malcolm Macleod, Virginia Chiocchia, Katharine A Smith, Argyris Stringaris, James Downs, Emma S J Robinson, Gin S Malhi, Dominic M Dwyer and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in EBioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Edoardo G OstinelliDepartment of Psychiatry, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK; Oxford Precision Psychiatry Lab, NIHR Oxford Health Biomedical Research Centre, Oxford, UK.
Georgia SalantiInstitute of Social and Preventive Medicine, University of Bern, Switzerland.
Malcolm MacleodCentre for Clinical Brain Sciences, University of Edinburgh, UK.
Virginia ChiocchiaInstitute of Social and Preventive Medicine, University of Bern, Switzerland.
Katharine A SmithDepartment of Psychiatry, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK; Oxford Precision Psychiatry Lab, NIHR Oxford Health Biomedical Research Centre, Oxford, UK.
Argyris StringarisFaculty of Brain Sciences, University College London, UK; First Department of Psychiatry, Aiginiteion Hospital, National and Kapodistrian University of Athens, Greece.
James DownsMQ Mental Health Research, London, UK.
Emma S J RobinsonSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, UK.
Gin S MalhiDepartment of Psychiatry, University of Oxford, Oxford, UK; Academic Department of Psychiatry, Kolling Institute, Northern Clinical School, Faculty of Medicine and Health, The University of Sydney, Australia; CADE Clinic and Mood-T, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, Australia.
Dominic M DwyerSchool of Psychology, Cardiff University, Cardiff, UK.
Astrid ChevanceUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, France; Centre d'Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu, F-75004, Paris, France.
Christoph CorrellDepartment of Psychiatry, Zucker Hillside Hospital, Northwell Health, New York, USA; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Germany.
Thomy ToniaInstitute of Social and Preventive Medicine, University of Bern, Switzerland.
Emily WheelerMQ Mental Health Research, London, UK.
Toshi A FurukawaDepartment of Health Promotion and Human Behavior/School of Public Health, Kyoto University, Kyoto, Kyoto Prefecture, Japan.
Diego A PizzagalliDepartment of Psychiatry, University of Oxford, Oxford, UK; Noel Drury, M.D. Institute for Translational Depression Discoveries, University of California, Irvine, CA, USA.
Michael BrowningDepartment of Psychiatry, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK.
Jennifer PottsDepartment of Psychiatry, University of Oxford, Oxford, UK; Oxford Precision Psychiatry Lab, NIHR Oxford Health Biomedical Research Centre, Oxford, UK.
Andrea CiprianiDepartment of Psychiatry, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK; Oxford Precision Psychiatry Lab, NIHR Oxford Health Biomedical Research Centre, Oxford, UK. Electronic address: andrea.cipriani@psych.ox.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41406507
PMCPMC12768854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.